pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Endocrinology & Metabolism · news · pharmadog
← back to Endocrinology & Metabolism
News · Endocrinology & Metabolism
224
stories
10d
Abbott teams with Google Health on AI-powered health insights app
fiercebiotech
10d
FDA to require notice of additives in food supply for the first time
stat
10d
BioMarin axes asset from $270M Inozyme takeover, ending run in rare metabolic indication
biospace
11d
Arpeggio plays final chord as biotech disbands on poor prospects for Nrf2 program
fiercebiotech
11d
Recon: BMS plans $2.3B Houston manufacturing site; MHRA approves Lilly weight-loss drug for weight loss, type 2 diabetes
raps
14d
Chutes & Ladders—BioNTech brings in Sobi CEO
fiercebiotech
14d
LifeMine raises $263M in mission to improve organ transplant aftercare
biospace
14d
CROs vs. biotechs: Finding the right fit
biospace
15d
5 NextGen winners who went public this year (and which ones are hiring)
biospace
16d
Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-up
fda medwatch
16d
Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data
fiercebiotech
16d
Vertex’s biggest overhang: a rival 50 times smaller
biopharma dive
16d
Trans federal employees sue over revoked health coverage
stat
17d
Heart transplant candidates fail if they get too weak. New program tries inpatient prehab
stat
20d
Novo's IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%
biospace
20d
‘It’s making a difference’: Madrigal CEO talks strategy behind MASH shopping spree
fiercebiotech
20d
Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail
fiercebiotech
21d
Labcorp posts higher Q2 earnings on strength of diagnostics, lab services; adjusts full-year guidance
fiercebiotech
21d
New funding, new jobs: 4 biotechs hiring after series B raises
biospace
22d
GSK pens $110M biological datasets pact with AI biotech Relation
fiercebiotech
22d
Private biotechs Caldera and Vidya raise $478M collectively in reverse go-public mergers
biospace
22d
AbCellera, Vertex partner on next-gen T-cell engagers
biopharma dive
23d
STAT+: American Diabetes Association, facing calls for resignations, asks for patience
stat
23d
Eli Lilly tops new biopharma ranking on launch success, development speed
fiercebiotech
23d
Altimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage study
biospace
23d
Anthony Fauci’s pandemic-era diary entries
stat
23d
Altimmune’s next-gen GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 alcohol use disorder win
fiercebiotech
23d
After PCOS became PMOS, there’s hope for new awareness among Black and Latina women
stat
24d
From confidence to capital: Positioning biotech for the next growth cycle
biopharma dive
24d
STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities
stat
← prev
page 2 of 8
next →
